Emmaus Life Sciences, Inc. (EMMA) has 170 open-market insider trades by 5 insiders since 2019. Over the last six months insiders net bought $15K. The most active filer is Yutaka Niihara, CEO & Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Yutaka Niihara | CEOChairman | — | 128 | $2.5M | 2022-11-30 |
| Wei Peu Zen | Dir | — | 5 | $446K | 2023-12-15 |
| Willis C. Lee | CEO | — | 33 | $445K | 2026-08-31 |
| Seah H. Lim | Dir | — | 3 | $34K | 2024-09-16 |
| Alfred Fu Kong Lui | Dir | — | 1 | $16K | 2022-01-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Willis C. Lee | CEO | Buy | $18K | 2025-05-30 |
| Seah H. Lim | Director | Buy | $800 | 2024-09-16 |
| Willis C. Lee | President | Buy | $15K | 2024-02-26 |
| Seah H. Lim | Director | Sell | $2K | 2023-12-20 |
| Seah H. Lim | Director | Sell | $660 | 2023-12-15 |
| Willis C. Lee | COO | Buy | $15K | 2023-08-25 |
Companies that share insiders with EMMA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Willis C. Lee | COO | Buy | $2K | 2023-08-25 |
| Yutaka Niihara | Chairman & 10% | Buy | $21K | 2022-11-03 |
| Yutaka Niihara | Chairman & 10% | Buy | $12K | 2022-10-31 |
| Yutaka Niihara | Chairman & 10% | Buy | $19K | 2022-10-24 |
| Yutaka Niihara | Chairman & 10% | Buy | $11K | 2022-10-19 |
| Yutaka Niihara | Chairman & 10% | Buy | $9K | 2022-10-17 |
| Yutaka Niihara | Chairman & 10% | Buy | $17K | 2022-10-13 |
| Yutaka Niihara | Chairman & 10% | Buy | $13K | 2022-10-11 |
| Seah H. Lim | Director | Buy | $31K | 2022-10-09 |